Impacts of p97 on Proteome Changes in Human Cells during Coronaviral Replication

Kai-Wen Cheng(California Institute of Technology), Tsui‐Fen Chou(California Institute of Technology)

Cells

October 29, 2021

10.3390/cells10112953

Cited by 9

Related Papers

Reversible inhibitor of p97, DBeQ, impairs both ubiquitin-dependent and autophagic protein clearance pathways

|Proceedings of the National Academy of Sciences|2011|323

Skeletal muscle cell protein dysregulation highlights the pathogenesis mechanism of myopathy-associated p97/VCP R155H mutations

|Frontiers in Neurology|2023|1

Skeletal muscle cell protein dysregulation highlights the pathogenesis mechanism of myopathy-associated p97/VCP R155H mutations.

|Research Square|2022|0